Transducin-like enhancer protein 2 (TLE2) is a transcriptional corepressor that plays pivotal roles in the regulation of gene expression and developmental processes. Functionally, TLE2 belongs to the Groucho/TLE family of proteins, which interact with various transcription factors and histone-modifying enzymes to repress gene transcription. TLE2 is involved in diverse biological processes, including embryonic development, cell fate determination, and tissue homeostasis. Through its interactions with transcription factors such as members of the Wnt, Notch, and nuclear hormone receptor families, TLE2 mediates transcriptional repression by recruiting histone deacetylases and other chromatin-modifying enzymes to target gene promoters, thereby maintaining gene silencing and regulating cell differentiation and proliferation.
The activation of TLE2 is governed by complex regulatory mechanisms involving post-translational modifications, protein-protein interactions, and cellular signaling pathways. One of the primary mechanisms regulating TLE2 activity is through its phosphorylation status, which can modulate its interaction with transcription factors and other coregulators. Additionally, TLE2 activation can be influenced by various signaling pathways, including the Wnt and Notch pathways, which regulate its nuclear localization and interaction with specific transcriptional complexes. Furthermore, TLE2 activity may be modulated by protein-protein interactions with cofactors and accessory proteins, which regulate its recruitment to target gene promoters and its repressive function. Overall, elucidating the precise mechanisms underlying TLE2 activation provides valuable insights into its role in transcriptional regulation and developmental processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 is a histone demethylase inhibitor that targets KDM3 and KDM4 subfamilies. Inhibition of these demethylases may influence histone modifications, potentially impacting the transcriptional regulation of genes, including those related to TLE2. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 is a histone methyltransferase inhibitor targeting the G9a and GLP methyltransferases. Inhibition of these enzymes may alter histone methylation patterns, potentially impacting gene expression, including that of TLE2. | ||||||
LDN-214117 | 1627503-67-6 | sc-507451 | 5 mg | $165.00 | ||
LDN-214117 is a selective BMP type I receptor kinase inhibitor. Inhibition of BMP signaling may affect downstream pathways involved in TLE2 expression regulation. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
CHIR-99021 is a selective inhibitor of GSK-3β. Inhibition of GSK-3β can stabilize β-catenin, influencing Wnt/β-catenin signaling, and indirectly impacting TLE2 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. Inhibition of JNK can affect the activity of AP-1 transcription factors, potentially influencing TLE2 expression. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide is an inhibitor of the Wnt/β-catenin pathway. It disrupts the interaction between β-catenin and TCF4, thereby inhibiting Wnt signaling and indirectly affecting TLE2 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is a histone deacetylase inhibitor. It can alter histone acetylation patterns, impacting chromatin structure and gene expression, including potential effects on TLE2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Inhibition of PI3K can influence the activity of downstream signaling pathways, potentially impacting TLE2 expression. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a CaMKII inhibitor. Inhibition of CaMKII can impact downstream signaling pathways, potentially influencing TLE2 expression. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662 is a PPARγ antagonist. Modulation of PPARγ activity may influence gene expression, potentially impacting TLE2 expression. | ||||||